Please select the option that best describes you:
What systemic therapy would you choose for elderly patients with HER2+ breast CA who have early metastatic relapse (within months) of completing adjuvant trastuzumab/paclitaxel?
What would you offer if the patient is not a candidate for cytotoxic therapy?
Answer from: Medical Oncologist at Academic Institution
Yes, even our frail older patients may have pretty aggressive HER2+ cancers. I am treating a lovely older lady who is on her 6th line of therapy and has responded to everything she's had, so far! We've been working together for about 7 years! Initially, I stuck to pretty standard regimens with dose ...
Sign in or Register to read more